Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Markus Warmuth currently holds 613,471 shares of Monte Rosa Therapeutics, Inc. (GLUE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Markus Warmuth has been a net seller of GLUE stock. They have purchased $0 and sold $98.0K worth of shares.
Markus Warmuth's most recent insider trade was on Mar 2, 2026, when they sold 5,466 shares at $17.92 per share.
Markus Warmuth serves as Executive at Monte Rosa Therapeutics, Inc. (GLUE). They have executed 2 insider transactions totaling $98.0K over their tenure at the company.
Markus Warmuth holds the position of Executive at Monte Rosa Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Markus Warmuth has shown a selling trading pattern, with $0 in total purchases and $98.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Markus Warmuth was on Mar 2, 2026, when they sold $98.0K worth of GLUE shares. This transaction involved 5,466 shares at $17.92 per share.
Markus Warmuth currently owns 613,471 shares of Monte Rosa Therapeutics, Inc. (GLUE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Markus Warmuth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Markus Warmuth has 2 Form 4 filings on record as an insider at Monte Rosa Therapeutics, Inc..
Set alerts for Markus Warmuth and 40,000+ other insiders.